Novo Nordisk Launches Highly Anticipated Ozempic in India, Amidst Global Weight-Loss Buzz
Global pharmaceutical giant Novo Nordisk officially introduced its much-talked-about drug, Ozempic (semaglutide), to the Indian market on 12th December. Positioned primarily as a treatment for Type 2 Diabetes Mellitus, the once-weekly…

